Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06820385 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Testing a WearabLE Artificial Intelligence-POwered Device For OPtimal DAily RaDiation Therapy Using Image Guidance

Study acronym: LEOPARD-IG
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint added 0 → 1 primary endpoints
See other at-risk trials from Medical College of Wisconsin

Record History

  1. Notable Primary endpoint(s) modified Phase changed: not specified → not applicable · Sponsor changed: [Redacted] to Medical College of Wisconsin · Trial status changed: Withheld → Recruiting · 6 more Show 9 more changesShow less
    • Phase changed: not specified → not applicable
    • Sponsor changed: [Redacted] to Medical College of Wisconsin
    • Trial status changed: Withheld → Recruiting
    • Enrollment changed: None → 15
    • Interventions modified
    • Trial arms changed: 0 → 2
    • Primary and study completion dates: Oct 30, 2026
    • Start date: May 2, 2025
    • Study title expanded, about 1 word
  2. Minor 3 versions Re-verified since Jun 17, 2025, no change to tracked fieldsv2-v4
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a device feasibility study to determine the feasibility of automatically predicting time to treatment readiness using a wearable imaging device (Fullyet) in both healthy volunteers and patients with pelvic malignancies undergoing radiation therapy.
Trial Details
NCT Number NCT06820385
Lead Sponsor Medical College of Wisconsin
Conditions Pelvic Malignancies
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov